SCMP Financial Facts

Other income (expense), net: 1.15M
Income tax benefit (provision): -1.29M
See Full Income Statement

Deferred revenue, non-current: -13.57M
Other liabilities: -1.58M
See Full Balance Sheet

Sucampo Pharmaceuticals (SCMP) Earnings

  |   Expand Research on SCMP
Next EPS Date N/A EPS Growth Rate +433.3% *Last Qtr.
Average EPS % Beat Rate -308.3% Revenue Growth Rate +145.4% *Last Qtr.
Average % Move 1-Wk after EPS +18.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
3/13/13 Q412 $0.32$0.12 +$0.20$34.9M$32.21M N/A +36% Details
3/13/12 Q411 $0.06N/A N/A $14.22M$15.9M N/A -11.1% Details
11/3/11 Q311 -$0.10N/A N/A $14.37M$20.9M N/A +68.3% Details
3/3/11 Q410 -$0.15-$0.01 -$0.14$12.4M$15.5M N/A +57.2% Details